Esophageal Cancer Clinical Trial

A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION

Summary

The purpose of this research study will be to determine the sensitivity and specificity of dwMRI metrics to assess tumor response following neoadjuvant chemoradiation in esophageal cancer. This pilot study will generate the preliminary data needed for the design of a statistically-justified trial that would investigate dwMRI as an integral biomarker to stratify patients for escalated therapy to improve outcomes. We hope to develop dwMRI as a predictive clinical tool for a personalized treatment model that can identify patients who may be candidates for organ-preservation or treatment intensification to improve outcomes in esophageal cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with a histologic diagnosis of adenocarcinoma of the esophagus located distal to the carina
Patients with AJCC 7th edition clinical stage IIB-IIIC
Patients will be treated with neoadjuvant chemoradiotherapy for this condition
Patients must be > 18 years of age
Patients must be able to provide informed consent
Patients must be surgical candidates
Patients must be able to tolerate MR imaging required by protocol

Exclusion Criteria:

Patients with primary tumors located above the carina
Prior abdominal radiation therapy with fields overlapping the current fields
Severe claustrophobia not relieved by oral anxiolytics per institutional standard practice
Presence of MRI-incompatible metallic objects or implanted medical devices in the body (including but not limited to: non-MRI compatible metal objects, cardiac pacemaker, aneurysm clips, artificial heart valves with steel parts, metal fragments in the eye or central nervous system)
Weight greater than that allowable by the MRI table

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

11

Study ID:

NCT03151642

Recruitment Status:

Completed

Sponsor:

Abramson Cancer Center of the University of Pennsylvania

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Abramson Cancer Center of the University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

11

Study ID:

NCT03151642

Recruitment Status:

Completed

Sponsor:


Abramson Cancer Center of the University of Pennsylvania

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider